301367 瑞迈特
已收盘 12-10 15:00:00
资讯
新帖
简况
瑞迈特：12月8日高管陈蓓减持股份合计900股
证券之星 · 12-09 21:03
瑞迈特：12月8日高管陈蓓减持股份合计900股
瑞迈特：12月5日高管陈蓓减持股份合计1.38万股
证券之星 · 12-08 21:03
瑞迈特：12月5日高管陈蓓减持股份合计1.38万股
【机构调研记录】淳厚基金调研工业富联、瑞迈特
证券之星 · 11-17
【机构调研记录】淳厚基金调研工业富联、瑞迈特
【机构调研记录】惠升基金调研瑞迈特
证券之星 · 11-17
【机构调研记录】惠升基金调研瑞迈特
股市必读：瑞迈特（301367）11月14日披露最新机构调研信息
证券之星 · 11-17
股市必读：瑞迈特（301367）11月14日披露最新机构调研信息
瑞迈特：11月13日进行路演，包括知名机构趣时资产的多家机构参与
证券之星 · 11-14
瑞迈特：11月13日进行路演，包括知名机构趣时资产的多家机构参与
瑞迈特最新公告：股东陈蓓拟减持不超1.76%股份
证券之星 · 11-12
瑞迈特最新公告：股东陈蓓拟减持不超1.76%股份
【机构调研记录】摩根士丹利基金调研思瑞浦、瑞迈特等3只个股（附名单）
证券之星 · 11-10
【机构调研记录】摩根士丹利基金调研思瑞浦、瑞迈特等3只个股（附名单）
【机构调研记录】大成基金调研九洲集团、瑞迈特
证券之星 · 11-10
【机构调研记录】大成基金调研九洲集团、瑞迈特
【机构调研记录】东方阿尔法基金调研瑞迈特、智明达
证券之星 · 11-10
【机构调研记录】东方阿尔法基金调研瑞迈特、智明达
股市必读：瑞迈特（301367）11月7日披露最新机构调研信息
证券之星 · 11-10
股市必读：瑞迈特（301367）11月7日披露最新机构调研信息
瑞迈特：11月6日进行路演，包括知名机构盘京投资的多家机构参与
证券之星 · 11-07
瑞迈特：11月6日进行路演，包括知名机构盘京投资的多家机构参与
股市必读：瑞迈特（301367）10月31日披露最新机构调研信息
证券之星 · 11-03
股市必读：瑞迈特（301367）10月31日披露最新机构调研信息
瑞迈特：未收到大股东减持计划
证券之星 · 10-31
瑞迈特：未收到大股东减持计划
瑞迈特（301367）披露首次公开发行前限售股份上市流通提示性公告，10月31日股价上涨2.7%
证券之星 · 10-31
瑞迈特（301367）披露首次公开发行前限售股份上市流通提示性公告，10月31日股价上涨2.7%
【机构调研记录】蜂巢基金调研瑞迈特
证券之星 · 10-29
【机构调研记录】蜂巢基金调研瑞迈特
瑞迈特（301367）2025年三季报简析：营收净利润同比双双增长，应收账款上升
证券之星 · 10-29
瑞迈特（301367）2025年三季报简析：营收净利润同比双双增长，应收账款上升
瑞迈特(301367)9月30日股东户数0.8万户，较上期增加16.36%
证券之星 · 10-27
瑞迈特(301367)9月30日股东户数0.8万户，较上期增加16.36%
瑞迈特(301367.SZ)发布前三季度业绩，归母净利润1.8亿元，增长43.87%
智通财经 · 10-27
瑞迈特(301367.SZ)发布前三季度业绩，归母净利润1.8亿元，增长43.87%
从呼吸机到全场景健康管理，BMC瑞迈特以硬核技术构建呼吸健康生态护城河
智通财经 · 10-23
从呼吸机到全场景健康管理，BMC瑞迈特以硬核技术构建呼吸健康生态护城河
公司概况
公司名称：
北京瑞迈特医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2022-11-01
主营业务：
北京瑞迈特医疗科技股份有限公司的主营业务是呼吸健康领域医疗设备与耗材产品制造。公司的主要产品是呼吸健康领域医疗设备与耗材产品，并提供呼吸健康慢病管理服务。
发行价格：
119.88
{"stockData":{"symbol":"301367","market":"SZ","secType":"STK","nameCN":"瑞迈特","latestPrice":87.9,"timestamp":1765350195000,"preClose":88.1,"halted":0,"volume":711800,"delay":0,"changeRate":-0.0023,"floatShares":69943600,"shares":89600000,"eps":2.3468,"marketStatus":"已收盘","change":-0.2,"latestTime":"12-10 15:00:00","open":88.4,"high":88.76,"low":86.9,"amount":62700000,"amplitude":0.0211,"askPrice":87.9,"askSize":37,"bidPrice":87.89,"bidSize":2,"shortable":0,"etf":0,"ttmEps":2.3468,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765416600000},"marketStatusCode":5,"adr":0,"adjPreClose":88.1,"symbolType":"stock","openAndCloseTimeList":[[1765330200000,1765337400000],[1765342800000,1765350000000]],"highLimit":96.91,"lowLimit":79.29,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":89600000,"isCdr":false,"pbRate":2.65,"roa":"--","peRate":37.455258,"roe":"6.2%","epsLYR":1.74,"committee":-0.362319,"marketValue":7876000000,"turnoverRate":0.0102,"status":1,"floatMarketCap":6148000000},"requestUrl":"/m/hq/s/301367/wiki","defaultTab":"wiki","newsList":[{"id":"2590349529","title":"瑞迈特：12月8日高管陈蓓减持股份合计900股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590349529","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590349529?lang=zh_cn&edition=full","pubTime":"2025-12-09 21:03","pubTimestamp":1765285425,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月9日市场公开信息、上市公司公告及交易所披露数据整理，瑞迈特最新董监高及相关人员股份变动情况：2025年12月8日公司董事,高管陈蓓共减持公司股份900.0股，占公司总股本为0.001%。瑞迈特近半年内的董监高及核心技术人员增减持详情如下：瑞迈特的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出707.12万，融资余额减少；融券净流出2300.0，融券余额减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900037890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301367","BK0251"],"gpt_icon":0},{"id":"2589335325","title":"瑞迈特：12月5日高管陈蓓减持股份合计1.38万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2589335325","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589335325?lang=zh_cn&edition=full","pubTime":"2025-12-08 21:03","pubTimestamp":1765199016,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月8日市场公开信息、上市公司公告及交易所披露数据整理，瑞迈特最新董监高及相关人员股份变动情况：2025年12月5日公司董事,高管陈蓓共减持公司股份1.38万股，占公司总股本为0.0154%。瑞迈特近半年内的董监高及核心技术人员增减持详情如下：瑞迈特的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出650.99万，融资余额减少；融券净流出100.0，融券余额减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800032152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301367","BK0251"],"gpt_icon":0},{"id":"2584691783","title":"【机构调研记录】淳厚基金调研工业富联、瑞迈特","url":"https://stock-news.laohu8.com/highlight/detail?id=2584691783","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584691783?lang=zh_cn&edition=full","pubTime":"2025-11-17 08:02","pubTimestamp":1763337739,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月14日披露的机构调研信息，淳厚基金近期对2家上市公司进行了调研，相关名单如下：1）工业富联 调研纪要：公司预期2026年云服务商资本支出将超6,000亿美元，年增40%，AI服务器订单需求持续向上，产能按计划扩建。淳厚基金成立于2018年，截至目前，资产管理规模199.12亿元，排名124/211；资产管理规模199.11亿元，排名105/211；管理公募基金数33只，排名121/211；旗下公募基金经理10人，排名109/211。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700001953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2097828805.USD","LU1580142542.USD","LU2495084118.USD","LU0456827905.SGD","LU1255011170.USD","601138","LU1979443071.USD","LU2097828714.EUR","LU1997244956.HKD","LU2148510915.USD","LU2097828474.EUR","LU1781817850.SGD","LU1934453819.USD","LU1655091616.SGD","LU0210526637.USD","LU2289578879.USD","SGXZ49509284.SGD","LU1997245094.SGD","LU1997245177.USD","LU1064130708.USD","LU2097828631.EUR","LU0051755006.USD","301367","LU1064131003.USD","BK0214","SGXZ81163826.USD","LU2097828557.USD"],"gpt_icon":0},{"id":"2584691796","title":"【机构调研记录】惠升基金调研瑞迈特","url":"https://stock-news.laohu8.com/highlight/detail?id=2584691796","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584691796?lang=zh_cn&edition=full","pubTime":"2025-11-17 08:01","pubTimestamp":1763337706,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月14日披露的机构调研信息，惠升基金近期对1家上市公司进行了调研，相关名单如下：1）瑞迈特 调研纪要：新无噪音棉呼吸机自7月批量进入美国市场，第三季度RH动销逐月提升，随着医疗报销码取得，后续放量将更明显。惠升基金成立于2018年，截至目前，资产管理规模556.48亿元，排名84/211；资产管理规模556.48亿元，排名70/211；管理公募基金数47只，排名109/211；旗下公募基金经理11人，排名104/211。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700001929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301367","BK0251"],"gpt_icon":0},{"id":"2584693243","title":"股市必读：瑞迈特（301367）11月14日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2584693243","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584693243?lang=zh_cn&edition=full","pubTime":"2025-11-17 03:34","pubTimestamp":1763321654,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，瑞迈特报收于83.75元，上涨0.9%，换手率1.22%，成交量8562.0手，成交额7203.55万元。截至2025年6月30日，公司拥有666项国内有效专利，其中国内发明专利116项、实用新型专利404项、外观设计专利146项；海外授权专利共266项，含美国专利45项、欧洲专利38项、欧盟外观专利63项、土耳其专利20项、日本专利22项、澳大利亚专利6项、印度专利18项。未来将持续加大市场投入，依托设备基数扩大推动耗材业务稳步提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700001231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301367","BK0251"],"gpt_icon":0},{"id":"2583257742","title":"瑞迈特：11月13日进行路演，包括知名机构趣时资产的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2583257742","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583257742?lang=zh_cn&edition=full","pubTime":"2025-11-14 19:01","pubTimestamp":1763118108,"startTime":"0","endTime":"0","summary":"截至 2025年 6月 30日，公司拥有 666 项国内有效专利，其中国内发明专利 116项、国内实用新型专利 404项、国内外观设计专利 146项；海外授权专利共计 266项，其中包括美国专利 45项、欧洲专利 38项、欧盟外观专利 63项、土耳其专利 20项、日本专利 22项、澳大利亚专利 6项、印度专利 18项。瑞迈特主营业务：呼吸健康领域医疗设备与耗材产品的销售。该股最近90天内共有13家机构给出评级，买入评级12家，增持评级1家；过去90天内机构目标均价为104.4。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400033417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301367","BK0251"],"gpt_icon":0},{"id":"2582327119","title":"瑞迈特最新公告：股东陈蓓拟减持不超1.76%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2582327119","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582327119?lang=zh_cn&edition=full","pubTime":"2025-11-12 18:49","pubTimestamp":1762944587,"startTime":"0","endTime":"0","summary":"瑞迈特(301367.SZ)公告称，公司持股5%以上股东、董事、高级管理人员陈蓓计划减持不超过156.8万股，占公司总股本比例1.76%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200033454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301367","BK0251"],"gpt_icon":0},{"id":"2582181167","title":"【机构调研记录】摩根士丹利基金调研思瑞浦、瑞迈特等3只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2582181167","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582181167?lang=zh_cn&edition=full","pubTime":"2025-11-10 08:01","pubTimestamp":1762732904,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月7日披露的机构调研信息，摩根士丹利基金近期对3家上市公司进行了调研，相关名单如下：1）思瑞浦 调研纪要：推进外延并购是公司加快落实平台化发展战略的重要举措之一。摩根士丹利基金成立于2003年，截至目前，资产管理规模260.81亿元，排名109/211；资产管理规模260.81亿元，排名95/211；管理公募基金数60只，排名96/211；旗下公募基金经理14人，排名90/211。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000001553.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688536","BK0231","SGXZ81163826.USD","301367","BK0251","SGXZ49509284.SGD"],"gpt_icon":0},{"id":"2582119808","title":"【机构调研记录】大成基金调研九洲集团、瑞迈特","url":"https://stock-news.laohu8.com/highlight/detail?id=2582119808","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582119808?lang=zh_cn&edition=full","pubTime":"2025-11-10 08:01","pubTimestamp":1762732892,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月7日披露的机构调研信息，大成基金近期对2家上市公司进行了调研，相关名单如下：1）九洲集团 个股亮点：公司为数据中心、超算中心提供配电及UPS系统；公司目前与HUAWEI签署了战略协议共同开发布局超级充电站；公司的智能配网产品及解决方案可用于机场基站。2）瑞迈特 调研纪要：公司9月底启动线上经销转直销，预计第四季度起国内电商毛利率逐步提升，净利润贡献增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000001538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0156","300040","BK0078","BK0136","301367","BK0224","BK0028","BK0186"],"gpt_icon":0},{"id":"2582811933","title":"【机构调研记录】东方阿尔法基金调研瑞迈特、智明达","url":"https://stock-news.laohu8.com/highlight/detail?id=2582811933","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582811933?lang=zh_cn&edition=full","pubTime":"2025-11-10 08:01","pubTimestamp":1762732871,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月7日披露的机构调研信息，东方阿尔法基金近期对2家上市公司进行了调研，相关名单如下：1）瑞迈特 调研纪要：公司9月底启动线上经销转直销，预计第四季度起国内电商毛利率逐步提升，净利润贡献增加。2）智明达 调研纪要：目前公司在手订单中机载类产品占比最高，弹载类次之，合计超50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000001509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301367","BK0251","688636","BK0214"],"gpt_icon":0},{"id":"2582818772","title":"股市必读：瑞迈特（301367）11月7日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2582818772","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582818772?lang=zh_cn&edition=full","pubTime":"2025-11-10 02:31","pubTimestamp":1762713073,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，瑞迈特报收于89.5元，上涨3.79%，换手率3.13%，成交量2.19万手，成交额1.95亿元。来自机构调研要点：公司9月底启动线上经销向直销模式切换，预计第四季度新模式对业绩影响将逐步显现，国内电商毛利率水平有望提升。来自机构调研要点：公司正推进AI技术与医疗业务融合，在服务效率提升和设备检测优化方面开展技术储备。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000000975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301367"],"gpt_icon":0},{"id":"2581004323","title":"瑞迈特：11月6日进行路演，包括知名机构盘京投资的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2581004323","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581004323?lang=zh_cn&edition=full","pubTime":"2025-11-07 19:33","pubTimestamp":1762515197,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年11月7日瑞迈特发布公告称公司于2025年11月6日进行路演，南方基金、东方阿尔法基金、摩根士丹利基金、华西基金、前海联合基金、中再资产、兆天投资、财通基金、兴业基金、盘京投资、华西证券、安信基金、太平洋医药、国泰海通医药、中邮基金、衍盛资产、东方基金、中银医药、大成基金、信达澳亚基金、招商基金、万和证券、富荣基金、国联基金、深圳民森投资参与。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700033591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301367"],"gpt_icon":0},{"id":"2580258102","title":"股市必读：瑞迈特（301367）10月31日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2580258102","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580258102?lang=zh_cn&edition=full","pubTime":"2025-11-03 08:57","pubTimestamp":1762131473,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，瑞迈特报收于81.41元，上涨2.7%，换手率1.6%，成交量9020.0手，成交额7348.11万元。截至2025年6月30日，公司拥有666项国内有效专利，其中国内发明专利116项、实用新型专利404项、外观设计专利146项；海外授权专利266项，涵盖美国、欧洲、日本、澳大利亚、印度等多个国家和地区。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300002691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301367"],"gpt_icon":0},{"id":"2579464756","title":"瑞迈特：未收到大股东减持计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2579464756","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579464756?lang=zh_cn&edition=full","pubTime":"2025-10-31 20:52","pubTimestamp":1761915162,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞迈特10月31日在投资者关系平台上答复投资者关心的问题。大股东的限售股份快解禁了，但公司股价一直低迷。请问大股东有考虑承诺不减持提振投资者信心吗？感谢您对瑞迈特的关注！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100047260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301367"],"gpt_icon":0},{"id":"2579450438","title":"瑞迈特（301367）披露首次公开发行前限售股份上市流通提示性公告，10月31日股价上涨2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579450438","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579450438?lang=zh_cn&edition=full","pubTime":"2025-10-31 18:34","pubTimestamp":1761906859,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，瑞迈特报收于81.41元，较前一交易日上涨2.7%，最新总市值为72.94亿元。公司近日发布《关于首次公开发行前限售股份上市流通提示性公告》，宣布首次公开发行前限售股份即将上市流通。解除限售股份数量为32,810,725股，占公司总股本36.62%。实际可上市流通数量为13,506,941股，上市流通日期为2025年11月4日。公司总股本为89,600,000股，其中有限售条件股份占比由37.01%降至21.94%，无限售条件股份占比升至78.06%。保荐机构对本次限售股上市流通无异议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100040096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301367","BK0251"],"gpt_icon":0},{"id":"2579146929","title":"【机构调研记录】蜂巢基金调研瑞迈特","url":"https://stock-news.laohu8.com/highlight/detail?id=2579146929","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579146929?lang=zh_cn&edition=full","pubTime":"2025-10-29 08:06","pubTimestamp":1761696399,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及10月28日披露的机构调研信息，蜂巢基金近期对1家上市公司进行了调研，相关名单如下：1）瑞迈特 调研纪要：第三季度境外业务收入2.05亿元，同比增长40.41%，美国市场贡献突出，收入同比增长63.46%。蜂巢基金成立于2018年，截至目前，资产管理规模430.47亿元，排名90/210；资产管理规模430.46亿元，排名84/210；管理公募基金数57只，排名99/210；旗下公募基金经理9人，排名112/210。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900012550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301367","BK0251"],"gpt_icon":0},{"id":"2579916420","title":"瑞迈特（301367）2025年三季报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2579916420","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579916420?lang=zh_cn&edition=full","pubTime":"2025-10-29 06:45","pubTimestamp":1761691517,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期瑞迈特发布2025年三季报。截至本报告期末，公司营业总收入8.08亿元，同比上升34.24%，归母净利润1.8亿元，同比上升43.87%。按单季度数据看，第三季度营业总收入2.64亿元，同比上升20.22%，第三季度归母净利润4866.3万元，同比上升48.61%。本报告期瑞迈特应收账款上升，应收账款同比增幅达42.93%。持有瑞迈特最多的基金为汇添富医药保健混合，目前规模为24.86亿元，最新净值2.013，较上一交易日下跌1.37%，近一年上涨23.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900011000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301367"],"gpt_icon":0},{"id":"2578961629","title":"瑞迈特(301367)9月30日股东户数0.8万户，较上期增加16.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578961629","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578961629?lang=zh_cn&edition=full","pubTime":"2025-10-27 17:17","pubTimestamp":1761556650,"startTime":"0","endTime":"0","summary":"证券之星消息，近日瑞迈特披露，截至2025年9月30日公司股东户数为7971.0户，较6月30日增加1121.0户，增幅为16.36%。在医疗器械行业个股中，瑞迈特股东户数低于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.14万户。从股价来看，2025年6月30日至2025年9月30日，瑞迈特区间跌幅为0.92%，在此期间股东户数增加1121.0户，增幅为16.36%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700023680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301367","BK0251"],"gpt_icon":0},{"id":"2578061528","title":"瑞迈特(301367.SZ)发布前三季度业绩，归母净利润1.8亿元，增长43.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578061528","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578061528?lang=zh_cn&edition=full","pubTime":"2025-10-27 17:03","pubTimestamp":1761555801,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑞迈特(301367.SZ)发布2025年三季度报告，该公司前三季度营业收入为8.08亿元，同比增长34.24%。归属于上市公司股东的净利润为1.8亿元，同比增长43.87%。归属于上市公司股东的扣除非经常性损益的净利润为1.4亿元，同比增长63.41%。基本每股收益为2.0252元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1360400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"瑞迈特(301367.SZ)发布前三季度业绩，归母净利润1.8亿元，增长43.87%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301367"],"gpt_icon":0},{"id":"2577032840","title":"从呼吸机到全场景健康管理，BMC瑞迈特以硬核技术构建呼吸健康生态护城河","url":"https://stock-news.laohu8.com/highlight/detail?id=2577032840","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577032840?lang=zh_cn&edition=full","pubTime":"2025-10-23 11:29","pubTimestamp":1761190150,"startTime":"0","endTime":"0","summary":"10月22日，国产呼吸健康领域领军企业BMC瑞迈特在媒体沟通会上，系统分享了公司在核心技术突破、全球市场拓展以及呼吸健康生态构建方面的战略路径与成果。2012年，BMC瑞迈特成为中国首家获得美国FDA认证的家用呼吸机品牌。截至2025年1月31日，BMC瑞迈特的家用呼吸机国内外累计销量突破300万台，通气面罩销量超过1000万只。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1358556.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","301367"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765364774603,"stockEarnings":[{"period":"1week","weight":-0.0861},{"period":"1month","weight":-0.0156},{"period":"3month","weight":-0.0356},{"period":"6month","weight":0.0483},{"period":"1year","weight":0.3069},{"period":"ytd","weight":0.4048}],"compareEarnings":[{"period":"1week","weight":0.003},{"period":"1month","weight":-0.022},{"period":"3month","weight":0.0255},{"period":"6month","weight":0.149},{"period":"1year","weight":0.149},{"period":"ytd","weight":0.1664}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京瑞迈特医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"7971人(较上一季度增加16.36%)","perCapita":"8774股","listingDate":"2022-11-01","address":"北京市海淀区阜成路115号丰裕写字楼A座110号","registeredCapital":"8960万元","survey":" 北京瑞迈特医疗科技股份有限公司的主营业务是呼吸健康领域医疗设备与耗材产品制造。公司的主要产品是呼吸健康领域医疗设备与耗材产品，并提供呼吸健康慢病管理服务。","listedPrice":119.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑞迈特(301367)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑞迈特(301367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑞迈特,301367,瑞迈特股票,瑞迈特股票老虎,瑞迈特股票老虎国际,瑞迈特行情,瑞迈特股票行情,瑞迈特股价,瑞迈特股市,瑞迈特股票价格,瑞迈特股票交易,瑞迈特股票购买,瑞迈特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑞迈特(301367)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑞迈特(301367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}